US 12,403,112 B2
Agent for preventing, ameliorating, or treating periodontal disease
Masahiro Ohtani, Akitakata (JP); and Tsubasa Nishimura, Akitakata (JP)
Assigned to WAKUNAGA PHARMACEUTICAL CO., LTD., Osaka (JP)
Appl. No. 17/610,973
Filed by WAKUNAGA PHARMACEUTICAL CO., LTD., Osaka (JP)
PCT Filed May 13, 2020, PCT No. PCT/JP2020/019096
§ 371(c)(1), (2) Date Nov. 12, 2021,
PCT Pub. No. WO2020/230813, PCT Pub. Date Nov. 19, 2020.
Claims priority of application No. 2019-091444 (JP), filed on May 14, 2019.
Prior Publication US 2022/0273597 A1, Sep. 1, 2022
Int. Cl. A61K 31/198 (2006.01); A61P 1/02 (2006.01)
CPC A61K 31/198 (2013.01) [A61P 1/02 (2018.01)] 4 Claims
OG exemplary drawing
 
1. A method for preventing, ameliorating, or treating periodontal disease in a subject in need thereof, the method comprising:
administering to or ingesting by the subject isolated S-1-propenylcysteine or a salt thereof.